Trimazosin
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Trimazosin is a sympatholytic alpha-1 blocker.[1][2]
References
- S2CID 19123951.
- ^ U.S. patent 3,669,968
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
NY (what is this?) (verify) |
Trimazosin is a sympatholytic alpha-1 blocker.[1][2]
| |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||||||||||||||||||||||||
Other antagonists |
| ||||||||||||||||||||||||||
|